Report Detail

Pharma & Healthcare Global (United States, European Union and China) Neprilysin Market Research Report 2019-2025

  • RnM3363731
  • |
  • 13 July, 2020
  • |
  • Global
  • |
  • 117 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Neprilysin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neprilysin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Neprilysin market is segmented into
TD-0714
STR-324
PL-265
LHW-090
Others

Segment by Application, the Neprilysin market is segmented into
Acute Heart Failure
Cancer Pain
Hypertension
Alzheimer's Disease
Others

Regional and Country-level Analysis
The Neprilysin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Neprilysin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Neprilysin Market Share Analysis
Neprilysin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Neprilysin business, the date to enter into the Neprilysin market, Neprilysin product introduction, recent developments, etc.

The major vendors covered:
Bioprojet SCR
Novartis AG
Pharmaleads SA
Theravance Biopharma Inc
...


1 Study Coverage

  • 1.1 Neprilysin Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Neprilysin Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Neprilysin Market Size Growth Rate by Type
    • 1.4.2 TD-0714
    • 1.4.3 STR-324
    • 1.4.4 PL-265
    • 1.4.5 LHW-090
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Neprilysin Market Size Growth Rate by Application
    • 1.5.2 Acute Heart Failure
    • 1.5.3 Cancer Pain
    • 1.5.4 Hypertension
    • 1.5.5 Alzheimer's Disease
    • 1.5.6 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Neprilysin Market Size, Estimates and Forecasts
    • 2.1.1 Global Neprilysin Revenue 2015-2026
    • 2.1.2 Global Neprilysin Sales 2015-2026
  • 2.2 Global Neprilysin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Neprilysin Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Neprilysin Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Neprilysin Competitor Landscape by Players

  • 3.1 Neprilysin Sales by Manufacturers
    • 3.1.1 Neprilysin Sales by Manufacturers (2015-2020)
    • 3.1.2 Neprilysin Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Neprilysin Revenue by Manufacturers
    • 3.2.1 Neprilysin Revenue by Manufacturers (2015-2020)
    • 3.2.2 Neprilysin Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Neprilysin Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Neprilysin Revenue in 2019
    • 3.2.5 Global Neprilysin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Neprilysin Price by Manufacturers
  • 3.4 Neprilysin Manufacturing Base Distribution, Product Types
    • 3.4.1 Neprilysin Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Neprilysin Product Type
    • 3.4.3 Date of International Manufacturers Enter into Neprilysin Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Neprilysin Market Size by Type (2015-2020)
    • 4.1.1 Global Neprilysin Sales by Type (2015-2020)
    • 4.1.2 Global Neprilysin Revenue by Type (2015-2020)
    • 4.1.3 Neprilysin Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Neprilysin Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Neprilysin Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Neprilysin Revenue Forecast by Type (2021-2026)
    • 4.2.3 Neprilysin Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Neprilysin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Neprilysin Market Size by Application (2015-2020)
    • 5.1.1 Global Neprilysin Sales by Application (2015-2020)
    • 5.1.2 Global Neprilysin Revenue by Application (2015-2020)
    • 5.1.3 Neprilysin Price by Application (2015-2020)
  • 5.2 Neprilysin Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Neprilysin Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Neprilysin Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Neprilysin Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Neprilysin by Country
    • 6.1.1 North America Neprilysin Sales by Country
    • 6.1.2 North America Neprilysin Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Neprilysin Market Facts & Figures by Type
  • 6.3 North America Neprilysin Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Neprilysin by Country
    • 7.1.1 Europe Neprilysin Sales by Country
    • 7.1.2 Europe Neprilysin Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Neprilysin Market Facts & Figures by Type
  • 7.3 Europe Neprilysin Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Neprilysin by Region
    • 8.1.1 Asia Pacific Neprilysin Sales by Region
    • 8.1.2 Asia Pacific Neprilysin Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Neprilysin Market Facts & Figures by Type
  • 8.3 Asia Pacific Neprilysin Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Neprilysin by Country
    • 9.1.1 Latin America Neprilysin Sales by Country
    • 9.1.2 Latin America Neprilysin Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Neprilysin Market Facts & Figures by Type
  • 9.3 Central & South America Neprilysin Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Neprilysin by Country
    • 10.1.1 Middle East and Africa Neprilysin Sales by Country
    • 10.1.2 Middle East and Africa Neprilysin Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Neprilysin Market Facts & Figures by Type
  • 10.3 Middle East and Africa Neprilysin Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Bioprojet SCR
    • 11.1.1 Bioprojet SCR Corporation Information
    • 11.1.2 Bioprojet SCR Description and Business Overview
    • 11.1.3 Bioprojet SCR Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bioprojet SCR Neprilysin Products Offered
    • 11.1.5 Bioprojet SCR Related Developments
  • 11.2 Novartis AG
    • 11.2.1 Novartis AG Corporation Information
    • 11.2.2 Novartis AG Description and Business Overview
    • 11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis AG Neprilysin Products Offered
    • 11.2.5 Novartis AG Related Developments
  • 11.3 Pharmaleads SA
    • 11.3.1 Pharmaleads SA Corporation Information
    • 11.3.2 Pharmaleads SA Description and Business Overview
    • 11.3.3 Pharmaleads SA Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Pharmaleads SA Neprilysin Products Offered
    • 11.3.5 Pharmaleads SA Related Developments
  • 11.4 Theravance Biopharma Inc
    • 11.4.1 Theravance Biopharma Inc Corporation Information
    • 11.4.2 Theravance Biopharma Inc Description and Business Overview
    • 11.4.3 Theravance Biopharma Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Theravance Biopharma Inc Neprilysin Products Offered
    • 11.4.5 Theravance Biopharma Inc Related Developments
  • 11.1 Bioprojet SCR
    • 11.1.1 Bioprojet SCR Corporation Information
    • 11.1.2 Bioprojet SCR Description and Business Overview
    • 11.1.3 Bioprojet SCR Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bioprojet SCR Neprilysin Products Offered
    • 11.1.5 Bioprojet SCR Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Neprilysin Market Estimates and Projections by Region
    • 12.1.1 Global Neprilysin Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Neprilysin Revenue Forecast by Regions 2021-2026
  • 12.2 North America Neprilysin Market Size Forecast (2021-2026)
    • 12.2.1 North America: Neprilysin Sales Forecast (2021-2026)
    • 12.2.2 North America: Neprilysin Revenue Forecast (2021-2026)
    • 12.2.3 North America: Neprilysin Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Neprilysin Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Neprilysin Sales Forecast (2021-2026)
    • 12.3.2 Europe: Neprilysin Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Neprilysin Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Neprilysin Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Neprilysin Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Neprilysin Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Neprilysin Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Neprilysin Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Neprilysin Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Neprilysin Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Neprilysin Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Neprilysin Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Neprilysin Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Neprilysin Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Neprilysin Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Neprilysin Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Neprilysin Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Neprilysin. Industry analysis & Market Report on Neprilysin is a syndicated market report, published as Global (United States, European Union and China) Neprilysin Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Neprilysin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,065.40
    4,598.10
    6,130.80
    3,603.60
    5,405.40
    7,207.20
    610,662.00
    915,993.00
    1,221,324.00
    324,831.00
    487,246.50
    649,662.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report